After presentation of data from our previous study' of this subject, we continued to encounter terminology during IRB sessions whose meanings we questioned whether or not research study participants understood. Our board members had lengthy discussions on the meanings of many terms used in participant consent forms and on participant comprehension. Of special note is the fact that the lay press has presented articles on difficulty patients have in understanding patient consent forms.
Discussion
Some of the data are interesting. For instance, in a standard consent form the term Institutional Review Board is frequently referred to. Yet only 12 percent of the overall lay population knew this term accurately. We were not surprised that the most common perception among the participants was that an Institutional Review Board is a committee that reviews your medical records to determine whether or not you should be institutionalized. We suggest that the consent form define the term as "committee that has reviewed this research project to help ensure that the rights and welfare of the participants are protected and that the study is carried out in an ethical manner."
Another term, sponsor, was not understood well by the lay population studied. We suggest the term be defined in the consent form, "he company that makes the test drug in this study," or other appropriate language. Similarly, we suggest the term, "study doctor," in place of the word investigator.
Analgesic did not score well, in spite of its frequent use in television commercials. We suggest the replacement of "pain medication" or "pain reliever."
The predominant answers given for the definition of serum probably stem from the radio days of Sergeant Preston and his dog, "King," who braved sleet, snow, and storm to get the "serum" delivered to save a young child. Most of the answers were slanted toward serum as being a drug! We suggest that wherever applicable the word "blood" be substituted for serum.
Baseline visit ranks along with similar terms, such as "screening visit," "run-in phase," and "washout period" used in many forms we see. We suggest the terms be deleted, and in their place the form use easily identified phrases, such as "first period," "second week," or "final phase."
In contrast to concomitant the term concurrent has a high level of understanding. The former is a word definitely to be avoided in lay consent forms. The data show that educational level plays a large role in understanding. However, we also see that clinical research jargon in a consent form can be detrimental to understanding the text.
When reviewing consent forms, it appears that the lack of understanding of clinical jargon by the lay population is a natural thing. In the medical profession, we use a jargon all our own and naively think that the rest of the world also understands. Often we see the symbols, "<", ">", and mg used. These are symbols that are not familiar to a lay population, and should be explained in the text of the forms. Often a detailed explanation is not needed, and merely confuses the potential study participant. When describing the amount of blood to be drawn, it may be better to express the volume in teaspoons, a common household measurement. Milligrams can be expressed as a fraction of an ounce in weight or an approximate number of grains of sand to give an idea of the small quantity with which one is dealing.
Shaping and molding consent forms to a common base lay language is a difficult task. But the rewards are directly proportional to the time and thinking, and of finding common lay terms to describe a final path. In our review of over fifty terms from consent forms we found a paucity of understanding by those lay populations for whose use they are intended. We found virtually no difference in data from one area of the country to another. It is hoped that presentation of these data from two studies may help in encouraging medical writers to use more common lay terms in preparing documents for clinical research participants. What does pruritis mean?
